Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Oligo-metastatic Prostate Carcinoma”

11 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 11 of 11 results

Testing effectiveness (Phase 2)Looking for participantsNCT07210086
What this trial is testing

Phase II Non-Randomized Study Evaluating POSLUMA-PSMA PET Response After Oligo- Metastatic/Progressive-directed Treatment With Radiotherapy (PROMPT-R)

Who this might be right for
Prostate Cancer
City of Hope Medical Center 50
Not applicableLooking for participantsNCT04983095
What this trial is testing

Metastasis Directed Stereotactic Body Radiotherapy for Oligo Metastatic Hormone Sensitive Prostate Cancer

Who this might be right for
Prostate Cancer MetastaticRadiation TherapyPositron-Emission Tomography
Karin Soderkvist 118
Not applicableStudy completedNCT02489357
What this trial is testing

Pembrolizumab and Cryosurgery in Treating Patients With Newly Diagnosed, Oligo-metastatic Prostate Cancer

Who this might be right for
Stage IV Prostate Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 12
Not applicableLooking for participantsNCT05183074
What this trial is testing

MR-linac Guided Ultra-hypofractionated RT for Prostate Cancer (SMART-P01 and SMART-P02)

Who this might be right for
Prostate CancerRadiotherapy Side EffectMagnetic Resonance-linac+4 more
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 50
Testing effectiveness (Phase 2)UnknownNCT02935023
What this trial is testing

Carbon Ion Radiotherapy in Treating Patients Undergoing Systemic Therapy for Oligo-metastatic Prostate Cancer

Who this might be right for
Metastatic Prostate Carcinoma
Shanghai Proton and Heavy Ion Center 47
Testing effectiveness (Phase 2)Looking for participantsNCT06654336
What this trial is testing

Study of Recurrence-directed Therapy (RDT) With or Without Androgen-Deprivation Therapy (ADT) In Patients With Radio-recurrent Oligo-metastatic Hormone/Castrate Sensitive Prostate Cancer (romCSPC)

Who this might be right for
Prostate AdenocarcinomaCastration Sensitive Prostate Cancer
Ontario Clinical Oncology Group (OCOG) 162
Not applicableNot Yet RecruitingNCT06198387
What this trial is testing

Radiotherapy for Prostate and Oligo-metastatic Lesions in Patients With Low-burden Oligo-metastatic Prostate Cancer

Who this might be right for
Oligo-metastatic Prostate Carcinoma
Changhai Hospital 30
Not applicableNot Yet RecruitingNCT07635108
What this trial is testing

MR-guided Single-fraction SBRT for Nodal Oligorecurrent Prostate Cancer (PINPOINT)

Who this might be right for
Prostate CancerOligo-metastatic Prostate CarcinomaOligometastatic Cancer+1 more
Odense University Hospital 48
Testing effectiveness (Phase 2)UnknownNCT05212857
What this trial is testing

Enhanced Systemic Combined With Local Treatment for Primary and Metastatic Lesions in Oligo-metastatic Prostate Cancer

Who this might be right for
Prostate Cancer
Fudan University 160
Not applicableActive Not RecruitingNCT07766486
What this trial is testing

Prospective Study on the Role of Radical Prostatectomy in Oligo-metastatic Hormone-sensitive Prostate Cancer in Patients on Androgen Deprivation Therapy

Who this might be right for
Oligometastatic Hormone-Sensitive Prostate CancerProstate Adenocarcinoma
Fondazione del Piemonte per l'Oncologia 30
Testing effectiveness (Phase 2)Study completedNCT04443062
What this trial is testing

Lutetium-177-PSMA-617 in Oligo-metastatic Hormone Sensitive Prostate Cancer

Who this might be right for
Prostate Cancer
Radboud University Medical Center 58